Skip to content
ClinCalc Pro
Menu
Local Anaesthetic (Amide)

Lidocaine (IV — Regional Anaesthesia)

Brand names: Xylocaine

This page concerns intravenous lidocaine used for regional anaesthesia (notably intravenous regional anaesthesia / Bier's block) and as a perioperative analgesic adjunct in orthopaedic and trauma care.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Lidocaine is an amide local anaesthetic that blocks voltage-gated sodium channels, preventing nerve impulse conduction; systemically it also has analgesic and anti-hyperalgesic effects.

Prescribing in practice

  • The principal hazard is local anaesthetic systemic toxicity (LAST) — perioral numbness and tinnitus progressing to seizures, cardiac arrhythmia and arrest — so respect maximum doses, use a functioning tourniquet for Bier's block and have lipid emulsion and resuscitation immediately available.
  • For intravenous regional anaesthesia the tourniquet must not be released prematurely, as sudden systemic release of the agent can precipitate toxicity.
  • Use with caution and reduced dosing in hepatic impairment, low cardiac output, the elderly and those with conduction defects; avoid in severe heart block.

Monitoring

Monitor ECG, blood pressure, conscious level and for early signs of systemic toxicity throughout administration.

Counselling the patient

  • Report ringing in the ears, tingling around the mouth, a metallic taste or dizziness immediately.
  • The tourniquet (cuff) stays inflated for a set time for your safety.
  • This provides numbness and pain relief for your procedure.

Evidence & guidelines

AAGBI/Association of Anaesthetists guidance on managing severe local anaesthetic systemic toxicity underpins safe intravenous lidocaine use and immediate lipid-emulsion availability.

Reference: AAGBI LAST Guidelines 2010; ASRA Regional Anaesthesia Guidelines; Miller's Anaesthesia; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.